Results 191 to 200 of about 71,512 (251)

Rapidly Progressive Cutaneous Nodules in an Elderly Woman

JEADV Clinical Practice, Volume 5, Issue 2, Page 737-741, June 2026.
Valeria Olvera‐Rodriguez, Gerardo González‐Martínez, Marion Carolina Alemán‐Jiménez, Minerva Gómez‐Flores, Jorge Ocampo‐Candiani, Lucía T. Fernández   +5 more
wiley   +1 more source

Plenary Abstracts Session & Oral Presentations

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

JAMA Oncol
Shadman M, LeBlanc M, Rimsza L, Leonard JP, Smith SM, Li H, Friedberg JW.   +6 more
europepmc   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vincristine revisited

Critical Reviews in Oncology/Hematology, 1999
Item does not contain ...
Gidding, C.E.M., Kellie, S.J., Kamps, W.A., Graaf, S.S.N. de   +3 more
openaire   +3 more sources

Overdosage with vincristine

The Journal of Pediatrics, 1976
Five patients received overdoses of vincristine ranging from 3.5 to 32 mg. Neurotoxicity accounted for most of the complications observed. Peripheral neuropathies, cranial nerve palsies, paralytic ileus, atony of the bladder, hypertension, hypotension, seizures, inappropriate ADH secretion, and severe bone marrow depression were all encountered.
I A, Kaufman, F H, Kung, H M, Koenig, S T, Giammona   +3 more
openaire   +2 more sources

Vincristine Poisoning

Pediatrics, 1980
Vincristine is an effective and potent antileukemic agent. Its FDA-approved labeling, ie, its package insert, does not contain directions for treatment of overdose. Several recent communications1-7 report accidental overdoses whose outcome was often fatal (Table).
openaire   +2 more sources